Literature DB >> 8575850

DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke.

P Vineis1, G Talaska, C Malaveille, H Bartsch, T Martone, P Sithisarankul, P Strickland.   

Abstract

Markers of exposure to polycyclic aromatic hydrocarbons (urinary 1-hydroxypyrene-glucuronide) and aromatic amines (4-aminobiphenyl-hemoglobin adducts), as well as urinary mutagenicity, were measured in 47 healthy smokers and 50 nonsmokers. DNA adducts were determined by P32-postlabeling in the exfoliated bladder cells of 39 healthy subjects. Both 1-hydroxypyrene-glucuronide (1-OHPG) and 4-aminobiphenyl adducts (4-ABP-Hb) were associated with smoking habits, but only 4-ABP-Hb adducts were associated with consumption of black, air-cured tobacco. The levels of 2 DNA adducts (numbers 2 and 4) in urothelial cells were clearly associated with 4-ABP-Hb adducts, in all subjects and in smokers. Levels of one of these DNA adducts (number 2) were also associated with 1-hydroxypyrene-glucuronide in urines, but in smokers the association was not statistically significant. Overall, these observations constitute further evidence of a role of arylamines in tobacco-induced bladder cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8575850     DOI: 10.1002/(SICI)1097-0215(19960126)65:3<314::AID-IJC6>3.0.CO;2-2

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

1.  Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai.

Authors:  Roman Corral; Juan Pablo Lewinger; David Van Den Berg; Amit D Joshi; Jian-Min Yuan; Manuela Gago-Dominguez; Victoria K Cortessis; Malcolm C Pike; David V Conti; Duncan C Thomas; Christopher K Edlund; Yu-Tang Gao; Yong-Bing Xiang; Wei Zhang; Yu-Chen Su; Mariana C Stern
Journal:  Int J Cancer       Date:  2014-01-13       Impact factor: 7.396

2.  Association between RAD51 polymorphisms and susceptibility of head and neck cancer: a meta-analysis.

Authors:  Fanliang Kong; Jin Wu; Lixia Hu; Yingying Du; Yueyin Pan
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population.

Authors:  Jingwen Wang; Yang Zhao; Jing Jiang; Vendhan Gajalakshmi; Kiyonori Kuriki; Seiichi Nakamura; Susumu Akasaka; Hideki Ishikawa; Sadao Suzuki; Teruo Nagaya; Shinkan Tokudome
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-15       Impact factor: 4.553

4.  Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.

Authors:  Qin Li; Tielong Tang; Peng Zhang; Chenlu Liu; Yan Pu; Yan Zhang; Huizi Song; Yanyun Wang; Yaping Song; Min Su; Bin Zhou; Lin Zhang
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

5.  An improved liquid chromatography-tandem mass spectrometry method for the quantification of 4-aminobiphenyl DNA adducts in urinary bladder cells and tissues.

Authors:  Kristen L Randall; Dayana Argoti; Joseph D Paonessa; Yi Ding; Zachary Oaks; Yuesheng Zhang; Paul Vouros
Journal:  J Chromatogr A       Date:  2009-11-10       Impact factor: 4.759

6.  Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.

Authors:  Mariana C Stern; Jie Lin; Jonine D Figueroa; Karl T Kelsey; Anne E Kiltie; Jian-Min Yuan; Giuseppe Matullo; Tony Fletcher; Simone Benhamou; Jack A Taylor; Donatella Placidi; Zuo-Feng Zhang; Gunnar Steineck; Nathaniel Rothman; Manolis Kogevinas; Debra Silverman; Nuria Malats; Stephen Chanock; Xifeng Wu; Margaret R Karagas; Angeline S Andrew; Heather H Nelson; D Timothy Bishop; Sei Chung Sak; Ananya Choudhury; Jennifer H Barrett; Faye Elliot; Román Corral; Amit D Joshi; Manuela Gago-Dominguez; Victoria K Cortessis; Yong-Bing Xiang; Yu-Tang Gao; Paolo Vineis; Carlotta Sacerdote; Simonetta Guarrera; Silvia Polidoro; Alessandra Allione; Eugen Gurzau; Kvetoslava Koppova; Rajiv Kumar; Peter Rudnai; Stefano Porru; Angela Carta; Marcello Campagna; Cecilia Arici; Sung Shim Lani Park; Montserrat Garcia-Closas
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

7.  Smoking-induced immune deviation contributes to progression of bladder and other cancers.

Authors:  Jessica M Clement; Fei Duan; Pramod K Srivastava
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

Review 8.  Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma.

Authors:  Gholamreza Roshandel; Shahryar Semnani; Reza Malekzadeh; Sanford M Dawsey
Journal:  Arch Iran Med       Date:  2012-11       Impact factor: 1.354

9.  Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.

Authors:  Yifei Wang; Zongping Li; Naibo Liu; Guan Zhang
Journal:  Tumour Biol       Date:  2013-11-22

10.  An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.

Authors:  Yan Zhang; Xinhua Wang; Wei Zhang; Shengkai Gong
Journal:  Tumour Biol       Date:  2012-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.